UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.11 +0.11 (+0.14%) GOLD FUTURES
2,315.40 +4.40 (+0.19%) DOW
38,263.20 +359.91 (+0.95%) Bitcoin GBP
47,402.50 +116.62 (+0.25%)
BioSyent Inc. (RX.V)
TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
As of 02:33PM EDT. Market open.
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 100.85M |
| Enterprise value | 75.88M |
| Trailing P/E | 16.37 |
| Forward P/E | 18.48 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.35 |
| Price/book (mrq) | 2.90 |
| Enterprise value/revenue | 2.40 |
| Enterprise value/EBITDA | 8.38 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.93 |
| 52-week change 3 | 18.23% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 9.26 |
| 52-week low 3 | 7.03 |
| 50-day moving average 3 | 8.59 |
| 200-day moving average 3 | 8.28 |
Share statistics
| Avg vol (3-month) 3 | 6.31k |
| Avg vol (10-day) 3 | 10.62k |
| Shares outstanding 5 | 11.61M |
| Implied shares outstanding 6 | 11.74M |
| Float 8 | 9M |
| % held by insiders 1 | 38.45% |
| % held by institutions 1 | 1.37% |
| Shares short (15 Apr 2024) 4 | 1.72k |
| Short ratio (15 Apr 2024) 4 | 0.27 |
| Short % of float (15 Apr 2024) 4 | N/A |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.01% |
| Shares short (prior month 15 Mar 2024) 4 | 1.25k |
Dividends & splits
| Forward annual dividend rate 4 | 0.18 |
| Forward annual dividend yield 4 | 2.07% |
| Trailing annual dividend rate 3 | 0.16 |
| Trailing annual dividend yield 3 | 1.84% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 30.13% |
| Dividend date 3 | 15 Mar 2024 |
| Ex-dividend date 4 | 28 Feb 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 20.45% |
| Operating margin (ttm) | 18.48% |
Management effectiveness
| Return on assets (ttm) | 11.39% |
| Return on equity (ttm) | 18.97% |
Income statement
| Revenue (ttm) | 31.59M |
| Revenue per share (ttm) | 2.64 |
| Quarterly revenue growth (yoy) | 10.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 7.76M |
| Net income avi to common (ttm) | 6.46M |
| Diluted EPS (ttm) | 0.53 |
| Quarterly earnings growth (yoy) | 20.90% |
Balance sheet
| Total cash (mrq) | 26.19M |
| Total cash per share (mrq) | 2.26 |
| Total debt (mrq) | 1.22M |
| Total debt/equity (mrq) | 3.51% |
| Current ratio (mrq) | 6.48 |
| Book value per share (mrq) | 2.96 |
Cash flow statement
| Operating cash flow (ttm) | 5.05M |
| Levered free cash flow (ttm) | 4.08M |
© 2024 Yahoo. All rights reserved.